These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 28418927)

  • 61. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
    Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
    J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3-5cm: A propensity score matching study.
    Li M; He J; Pan M; Yu Y; Pan Z; Xu B; Zhu J
    Dig Liver Dis; 2016 Sep; 48(9):1082-7. PubMed ID: 27365224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endovascular implantation of
    Sun H; Zhang M; Liu R; Liu Y; Hou Y; Wu C
    Future Oncol; 2018 May; 14(12):1165-1176. PubMed ID: 29334777
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
    Ha Y; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS; Park SR; Ryu MH; Ryoo BY; Kang YK; Kim KM
    Oncotarget; 2016 Nov; 7(45):74303-74313. PubMed ID: 27494871
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis].
    Xu GB; Xiong B; Long QY
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):367-71. PubMed ID: 24025139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus.
    Yu TZ; Zhang W; Liu QX; Li WH; Ma JQ; Zhang ZH; Yang MJ; Wang JH; Chen B; Zeng SC; Luo JJ; Liu LX; Yan ZP
    Oncotarget; 2017 Feb; 8(7):12108-12119. PubMed ID: 28076848
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lin LW; Yan LY; Ke K; Yang WZ; Lin JQ; Huang N
    Brachytherapy; 2023; 22(6):858-871. PubMed ID: 37574351
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study.
    Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G
    Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus.
    Liu S; Guo L; Li H; Zhang B; Sun J; Zhou C; Zhou J; Fan J; Ye Q
    Ann Surg Oncol; 2018 Jul; 25(7):2098-2104. PubMed ID: 29728879
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus.
    Li X; Ding X; Liu M; Wang J; Sun W; Teng Y; Xu Y; Wu H; Li W; Zhou L; Chen J
    Cancer Med; 2023 Aug; 12(16):16805-16814. PubMed ID: 37387602
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Transarterial chemoembolization in patients with hepatocellular carcinoma beyond Barcelona-Clinic Liver Cancer- B and portal vein tumor thrombosis: Experience from a tertiary care center.
    Anand S; Pottakkat B; Raja K; Chandrasekar S; Satheesh S
    Indian J Cancer; 2022; 59(3):325-329. PubMed ID: 33753610
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transarterial chemoembolisation (TACE) combined with endovascular implantation of an iodine-125 seed strand for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis versus TACE alone: a two-arm, randomised clinical trial.
    Yang M; Fang Z; Yan Z; Luo J; Liu L; Zhang W; Wu L; Ma J; Yang Q; Liu Q
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):211-9. PubMed ID: 24374800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. TACE with portal vein radioactive seeds for HCC with portal vein tumor thrombus: a meta-analysis.
    Yang SB; Zhang JH; Fu YF; Wang R
    Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):856-864. PubMed ID: 35238280
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis.
    Abdella H; Shaker MK; Montasser IF; Sobhi M; Aly H; Sayed A; Saleh S; El Dorry A
    Indian J Gastroenterol; 2018 Mar; 37(2):127-132. PubMed ID: 29532323
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Peng BG; He Q; Li JP; Zhou F
    Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of Naïve HCC Combined with Segmental or Subsegmental Portal Vein Tumor Thrombosis: Liver Resection
    Yu JI; Choi GS; Lim DH; Lee E; Joh JW; Kwon CHD; Kim JM; Kim S; Woo SY; Paik SW; Park HC
    Anticancer Res; 2018 Aug; 38(8):4919-4925. PubMed ID: 30061270
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and Efficacy of CT-Guided Iodine-125 Brachytherapy for Portal Vein Tumor Thrombus in Hepatocellular Carcinoma.
    Qiu Z; Yu C; Qiu X; Li Q; Li J; Chen Z; Chang S; Zhang S; Fan G; Wang S
    Acad Radiol; 2023 Sep; 30 Suppl 1():S53-S60. PubMed ID: 36882354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
    Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
    World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and safety of transcatheter arterial chemoembolization plus hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk.
    Wu Z; Gao J; Zhuang W; Yang J; Guo W
    J Cancer Res Ther; 2022 Apr; 18(2):345-351. PubMed ID: 35645099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.